Operation Engage Manchester
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Operation Engage Manchester

Operation Engage Manchester

Operation Engage Manchester has moved to Lowell

Top Local Drug Threat

Using local statistics as a guide, local DEA officials have identified the powerful synthetic opioid fentanyl and the stimulant methamphetamine as the top drug threats in the Manchester area. From August 2021 to August 2022, more than 107,000 Americans died from drug overdoses or poisonings. That number grew to over 110,000 from August 2022 to August 2023. 

Laboratory testing indicates 7 out of every 10 pills seized by DEA contain a lethal dose of fentanyl, an increase from 6 out of 10 in 2022.

DEA has also reported a widespread threat of fentanyl mixed with xylazine.

Furthermore, deaths due to methamphetamine have increased sharply since 2012.

 

Consider these statistics, compiled by DEA's Operation Prevention:

  • In 2022, 11% of 8th graders, 21.5% of 10th graders, and 32.6% of 12th graders reported using an illicit drug in the past year (2022 Monitoring the Future)
  • In 2023, 7 out of 10 fentanyl-laced pills contain a potentially lethal dose of fentanyl (Drug Enforcement Administration)
  • Fentanyl is 50 times more potent than heroin (Drugs of Abuse: A DEA Resource Guide: 2022 edition)
  • In 2021, fentanyl was the leading cause of death among Americans ages 18 to 49, more than car accidents, gun violence, or suicide (Centers for Disease Control, CDC WONDER online database released 1/2023)
  • In 2021, there were 292 drug overdose deaths per day in the United States. Seventy-five percent of those deaths were related to opioids (CDC WONDER)
  • 8.7 million Americans indicated misusing prescription pain relievers in 2021 (2021 National Survey of Drug Use and Health (NSDUH))
  • In 2022, one in eleven high school students said that, at least once in their lifetime, they had taken prescription drugs without a doctor’s prescription, or differently than how a doctor told them to use it (2022 Monitoring the Future)
  • Most prescription opioids used by high school seniors are obtained through a friend or relative — not through a prescription (2021 NSDUH)

 

See Related

Article: Concerns About Recent Rise in Methamphetamine (Makin' it Happen)
Latest Statistics: 2020 Drug Death Data (Office of Chief Medical Examiner)

Contact: Laura_Epstein@hassan.senate.gov

Senator Hassan, Congressman Pappas Introduce Bipartisan Legislation to Crack Down on Deadly Xylazine

Criminals Increasingly Mix Xylazine with Fentanyl to Increase Potency, Leading to Overdose Deaths in NH

WASHINGTON -- U.S. Senator Maggie Hassan and Congressman Chris Pappas introduced bipartisan, bicameral legislation to crack down on a highly dangerous sedative that poses a new threat in New Hampshire’s opioid epidemic. Xylazine is an easily accessible veterinary tranquilizer that criminals are mixing with fentanyl to increase its potency and lower their production costs, and the New Hampshire Department of Health and Human Services recently issued a health alert about the danger of its usage. Xylazine causes depressed breathing and heart rate, unconsciousness, necrosis, and even death, and naloxone does not reverse its effects because it is not an opioid. Senator Jeanne Shaheen also joined in introducing the legislation.

“Xylazine is hurting New Hampshire communities and contributing to the alarming rate of overdose deaths in our state,” Senator Hassan said. “Our bipartisan bill would take important steps to combat the abuse of xylazine by giving law enforcement more authority to crack down on the illicit distribution of this drug, including by putting stiffer penalties on criminals who are spreading this drug to our communities. My colleagues on both sides of the aisle are seeing the impact of this deadly drug in their states, and we will continue working together to move this critical bill forward.”

“As we continue to see xylazine being mixed with fentanyl, heroin, and other deadly drugs, it’s critical we take action to crack down on illegal use,” said Congressman Pappas. “This legislation would track the manufacture of xylazine, which is legally used as an animal tranquilizer, and ensure law enforcement has the resources needed to crack down on illegal drug traffickers. I hope that this legislation will be swiftly brought to the House floor for a vote, and I’ll continue working across the aisle, and alongside law enforcement and public safety experts, to craft comprehensive solutions that will help combat our ongoing addiction epidemic.”

“The prevalence of Narcan-resistant xylazine has exacerbated the substance use disorder crisis in New Hampshire and across the nation. The level of danger this creates for those who use it, either knowingly or not, is incredibly high and far too often turns deadly,” said Shaheen, who chairs the Senate Appropriations Subcommittee that funds anti-opioid grant programs. “Our communities have endured the unimaginable and overwhelming grief of losing loved ones to the fentanyl epidemic for too long, and the introduction of xylazine is exacerbating this public health crisis. I’m glad to partner with lawmakers from both sides of the aisle on this new bill that would classify xylazine as a Schedule III drug to help get it out of the hands of everyday Granite Staters and Americans. As chair of the Senate Appropriations Subcommittee that funds the Drug Enforcement Administration and other federal agencies working to combat the substance use disorder crisis, I’ll continue efforts to stop the flow of these illicit drugs from reaching our communities.” 

“Fentanyl and xylazine can be a lethal combination, and it is making New Hampshire’s opioid epidemic even worse,” said Colonel Nathan Noyes of the New Hampshire State Police. “This bipartisan bill from Senator Hassan, Representative Pappas, and Senator Shaheen will take crucial steps to help law enforcement go after the illegal use of this drug and help save lives.”

Despite alarming reports about the rise of xylazine, federal, state and local law enforcement do not have the tools necessary to effectively track it or crack down on traffickers using it to increase their profits.

The bipartisan, bicameral Combating Illicit Xylazine Act would address the current gap in federal law by:

  1. Imposing stronger penalties for the illicit use of xylazine;

  2. Enabling the Drug Enforcement Administration to track its manufacturing to ensure it is not diverted to the illicit market;

  3. Requiring a report on prevalence, risks, and recommendations to best regulate illicit use of xylazine;

  4. Ensuring all analogues of xylazine are covered when restricting its illicit use;

  5. Declaring xylazine an emerging drug threat.

Xylazine is a medication used by some veterinarians and farmers, and the bill cracks down on the illegal distribution of this drug while safeguarding access for professionals who use the drug legally. The bill is supported by the American Veterinary Medical Association.

Senator Hassan is working to crack down on illicit drug trafficking. Senator Hassan recently visited Mexico, Guatemala, and Honduras as part of a bipartisan congressional delegation trip to speak with foreign officials about efforts to crack down on drug trafficking. In addition, the most recent year-end funding bill included a measure backed by Senator Hassan to extend fentanyl analogue scheduling, in order to keep criminals from using loopholes to traffic deadly opioids. The Senator successfully worked to secure her bipartisan measure in the 2021 year-end funding bill to hold countries such as China accountable for facilitating America’s fentanyl-fueled substance misuse crisis. Senator Hassan also worked with her colleagues to pass into law the bipartisan INTERDICT Act, which has provided critical tools to Customs and Border Protection to help detect and intercept fentanyl and other illegal synthetic opioids. 

###

Drug Information

Get facts about how methamphetamine and fentanyl affect a user's body.

Fentanyl

Methamphetamine

Events

Check back soon for more events from Operation Engage Manchester!

Connect With Us!

Stay up to date with Operation Engage Manchester by signing up to receive email updates, following us at DEA New England @DEANewEngland, and using the hashtags #OpEngageNH and #EngagewithNH.

IMPORTANT NOTE:

Please DO NOT submit tips using the feedback form on this page.

Use the official tips page (https://www.dea.gov/submit-tip) to report what appears to you as a possible violation of controlled substances laws and regulations. 

Tips submitted to the feedback form below WILL NOT be addressed.

Contact Us

Email
If you want a reply, please provide your email address.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Operation Engage
  • Operation Engage Homepage
  • Operation Engage Divisions
    • All Divisions
    • Albuquerque
    • DMV
    • Fort Lauderdale
    • Glendale
    • Lowell
    • New Orleans
    • Philadelphia
    • Seattle
    • Southern California
    • St. Louis
    • Toledo

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster